Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2Polyps 1Neoplasms 1Nasopharyngeal Carcinoma 1Lung Neoplasms 1Laryngeal Neoplasms 1Laryngeal Diseases 1Hypopharyngeal Neoplasms 1Hypersensitivity 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Barrett Esophagus 1Adenomatous Polyps 1Adenoma 1

Interventions

Cisplatin 28Paclitaxel 19Radiotherapy 17Fluorouracil 13Drug Therapy 12camrelizumab 10toripalimab 8Carboplatin 8Radiation 7Capecitabine 7Radiotherapy, Intensity-Modulated 6sintilimab 5S 1 (combination) 5Esophagectomy 5tislelizumab 4nimotuzumab 4apatinib 4anlotinib 4Irinotecan 4Cetuximab 4Afatinib 4pembrolizumab 3durvalumab 3Vinorelbine 3Positron Emission Tomography Computed Tomography 3Oxaliplatin 3Nivolumab 3Immune Checkpoint Inhibitors 3Docetaxel 3Albumin-Bound Paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Esophageal Squamous Cell Carcinoma × Narrow Band Imaging × Clear all
NCT04170257 2019-11-20

Performance of White Light, NBI and Iodine Staining Endoscopy in the Diagnosis of Esophageal Lesions

Peking University Cancer Hospital & Institute

Phase NA Unknown
10,000 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Hypersensitivity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡